Humoral and cell-mediated immunity to Vero cell-derived influenza vaccine

被引:36
作者
Brühl, P [1 ]
Kerschbaum, A [1 ]
Kistner, O [1 ]
Barrett, N [1 ]
Dorner, F [1 ]
Gerencer, M [1 ]
机构
[1] Baxter Hyland Immuno, Dept Cellular Immunol, A-1221 Vienna, Austria
关键词
vaccine; influenza virus; Vero cells;
D O I
10.1016/S0264-410X(00)00316-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A candidate trivalent influenza whole virus vaccine produced in a continuous mammalian cell line (Vero), and analogous commercially available egg-derived vaccines, were compared for their ability to induce humoral and cell-mediated immunity in Balb/c mice. Substantial haemagglutination-inhibition titre and high levels of influenza virus-specific IgG were found in all groups of immunized mice, irrespective of the vaccine formulation. The IgG responses were predominantly of IgG1 and IgG2a/2b isotypes. Virus-specific secretory IgA antibodies were detected only in mice immunized intranasally with a live virus, derived either from Vero cells or eggs. T-cell proliferative responses and T-helper 1 type cytokine release was significantly higher in mice immunized with Vero cell-derived influenza vaccine compared to egg-derived vaccine formulations. We have demonstrated that the immunogenicity df the trivalent Vero cell-derived whole influenza virus vaccine was comparable to that of the equivalent egg-derived vaccine, with respect to humoral immune response and was superior with respect to cellular response. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1149 / 1158
页数:10
相关论文
共 33 条
  • [1] Baumgarth N, 1999, P NATL ACAD SCI USA, V96, P2250, DOI 10.1073/pnas.96.5.2250
  • [2] CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED CYTOTOXIC T-LYMPHOCYTES ARE NOT NECESSARY FOR HETEROTYPIC IMMUNITY TO INFLUENZA
    BENDER, BS
    BELL, WE
    TAYLOR, S
    SMALL, PA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (05) : 1195 - 1200
  • [3] Cytokine production after influenza vaccination in a healthy elderly population
    Bernstein, ED
    Gardner, EM
    Abrutyn, E
    Gross, P
    Murasko, DM
    [J]. VACCINE, 1998, 16 (18) : 1722 - 1731
  • [4] BUTCHKO GM, 1978, J IMMUNOL, V121, P2381
  • [5] Casali P, 1996, CURR TOP MICROBIOL, V210, P167
  • [6] CAVALLISFORZA L, 1972, BIOMETRIE GRUNDZUGE, P159
  • [7] MUCOSAL IMMUNOADJUVANT ACTIVITY OF LIPOSOMES - INDUCTION OF SYSTEMIC IGG AND SECRETORY IGA RESPONSES IN MICE BY INTRANASAL IMMUNIZATION WITH AN INFLUENZA SUBUNIT VACCINE AND COADMINISTERED LIPOSOMES
    DEHAAN, A
    GEERLIGS, HJ
    HUCHSHORN, JP
    VANSCHARRENBURG, GJM
    PALACHE, AM
    WILSCHUT, J
    [J]. VACCINE, 1995, 13 (02) : 155 - 162
  • [8] Immunopotentiation of humoral and cellular responses to inactivated influenza vaccines by two different adjuvants with potential for human use
    Deliyannis, G
    Jackson, DC
    Dyer, W
    Bates, J
    Coulter, A
    Harling-McNabb, L
    Brown, LE
    [J]. VACCINE, 1998, 16 (20) : 2058 - 2068
  • [9] GENERATION OF BOTH CROSS-REACTIVE AND VIRUS-SPECIFIC T-CELL POPULATIONS AFTER IMMUNIZATION WITH SEROLOGICALLY DISTINCT INFLUENZA-A VIRUSES
    EFFROS, RB
    DOHERTY, PC
    GERHARD, W
    BENNINK, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 145 (03) : 557 - 568
  • [10] Augmentation of human influenza A virus-specific cytotoxic T lymphocyte memory by influenza vaccine and adjuvanted carriers (ISCOMS)
    Ennis, FA
    Cruz, J
    Jameson, J
    Klein, M
    Burt, D
    Thipphawong, J
    [J]. VIROLOGY, 1999, 259 (02) : 256 - 261